Table 2.
Clinicopathological features of HCC patients which their tissue were determined by IHC.
| Patients (n = 40) | n (%) |
|---|---|
| Age (years) | |
| <50 | 19 (47.5) |
| ≥50 | 21 (52.5) |
| Range | 35–94 |
| Mean | 51.6 |
| Median | 50.5 |
| Sex | |
| Male | 35 (87.5) |
| Female | 5 (12.5) |
| HBsAg | |
| Negative | 11 (27.5) |
| Positive | 29 (72.5) |
| AFP | |
| <500 ng/mL | 24 (60) |
| ≥500 ng/mL | 14 (35) |
| Unknown | 2 (5) |
| Tumor size | |
| <5 cm | 13 (32.5) |
| ≥5 cm | 27 (67.5) |
| TP53 expression | |
| Negative | 20 (50) |
| Positive | 20 (50) |
| Ki-67 expression | |
| Negative (10%) | 9 (22.5) |
| Positive (≥10%) | 31 (77.5) |
HBsAg: hepatitis B surface antigen; AFP: alpha-fetoprotein; HCC: hepatocellular carcinoma; TP53: tumor protein p53.